- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04661306
The Better Sleep for Supporters With Insomnia Study (BeSSI)
Optimizing Efficiency and Impact of Internet-delivered Insomnia Treatment for Cancer Caregivers
Study Overview
Status
Intervention / Treatment
Detailed Description
Insomnia is a significant public health problem with substantial medical, psychological and financial ramifications. About 50-75% of the 3.5 million Americans who provide unpaid medical, practical, and/or emotional support for a loved one with cancer endorse clinically significant sleep disturbance. Understanding caregivers' psychosocial risk factors and needs, and the extent to which these are unique to the cancer caregiving context, will ensure appropriate and effective interventions for cancer caregivers with insomnia.
Existing psychosocial services for caregivers are primarily delivered in-person. Although such interventions are effective, they suffer from low enrollment, high dropout, and limited reach to caregivers who already have inadequate healthcare access, like caregivers from lower SES or those in rural areas. Digital health interventions can lower barriers to entry to supportive care for caregivers as they are conveniently accessible anywhere and anytime from an Internet-enabled device. Sleep Healthy Using the Internet (SHUTi) is a NCI-designated research-tested intervention that delivers cognitive-behavioral therapy for insomnia (CBT-I) and holds significant potential to accessibly treat insomnia for cancer caregivers. Most digital health interventions tested among caregivers, however, have been developed de novo for specific caregiving contexts. The implicit assumption underlying highly tailored interventions for caregivers is that caregivers have different deficits, risk factors, and needs from non-caregivers. This assumption has not often been tested, and therefore the extent to which caregivers want and need tailoring for digital health interventions is not known. This study is therefore designed to provide the data necessary to ensure the highest quality, impact, and efficiency from existing evidence-based digital health interventions to meet pressing psychosocial needs among cancer caregivers. Specifically, this study will directly inform next research steps for tailoring and testing SHUTi for optimal impact and reach among caregivers.
The SHUTi Program: SHUTi is a self-guided (i.e., automated), interactive, and tailored web-based program modeled on the primary tenants of face-to-face CBT-I (sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, relapse prevention). Intervention content is metered out over time through 6 "Cores." Users obtain access to a new Core based on a time and event-based schedule (e.g., 7 days after completion of previous Core). This schedule is consistent with the recommendation from a task force commissioned by the Academy of Sleep Medicine, which deemed that an average of 6 - 8 sessions constitutes "adequate treatment exposure". The SHUTi program relies on user-entered online Sleep Diaries to track progress and to tailor treatment recommendations (i.e., assign a "sleep restriction" window). Each Core acts as an online analog for the weekly sessions typically used when delivering CBT-I in a face-to-face format, following the same general structure: 1) Core objectives (what will be learned and why this information is important), 2) review of previous week's homework and sleep diary data, 3) new intervention material, 4) assignment of homework (treatment strategies for the coming week), and 5) a summary of the Core's main points. Intervention content is enhanced through a variety of interactive features, including personalized goal-setting, graphical feedback based on inputted symptoms, animations / illustrations to enhance comprehension, quizzes to test user knowledge, patient vignettes, and video-based expert explanation. Automated emails are also sent to encourage program adherence. There is no content that is specifically about cancer or caregiving.
Caregivers participating in this study will complete a baseline assessment (questionnaires and 2 weeks of daily sleep diaries), and then will receive complementary and voluntary access to SHUTi. Participants who choose to complete 1 or more SHUTi Cores will complete a follow-up assessment of questionnaires and 2 weeks of sleep diaries; participants who choose not to complete any SHUTi cores will be asked to provide brief feedback regarding their reasons/barriers.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22903
- University of Virginia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- self-report providing unpaid care (e.g., practical, medical, and/or emotional support) to an adult family member or "family-like" close individual who is either currently undergoing any anti-cancer treatment (e.g., surgery, chemotherapy, radiation, for either curative or palliative intent) or has completed anti-cancer treatment within the past 2 years.
- Insomnia severity index score of 10 or higher
- age 18 and over
- regular access (at least 2/week) and willingness to use a computer and the Internet and check email
- ability to read and speak English
- resident of the US
Exclusion Criteria:
- irregular sleep schedules that prevent the ability to follow intervention recommendations (i.e., with usual bedtimes outside of 8:00pm to 2:00am or arising time outside of 4:00am to 10:00am)
- current psychological treatment for insomnia
- screen positive for a history of psychotic or bipolar disorder; and current severe depression, high risk of suicide, substance use (alcohol, drug) disorder within the past year
- symptoms suggestive of untreated sleep disorders other than insomnia (e.g., obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder)
- presence of uncontrolled medical condition that is deemed to interfere with the study procedures, or put the study participant at undue risk
- Unstable medication regimen (change to schedule or dosage within past 3 months) for a prescription medication regimen thought to impact sleep.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SHUTi
|
Cognitive Behavioral Therapy for insomnia delivered online and metered out over 6 weeks in a fully automated, interactive, tailored web-based program
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SHUTi Usage
Time Frame: 9 weeks
|
Number of SHUTi Cores completed by participants
|
9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia severity
Time Frame: Baseline, 9 weeks
|
Insomnia severity index; 7 items; summed scores range from 0 to 28 (higher scores indicate more severe insomnia symptoms)
|
Baseline, 9 weeks
|
Sleep onset latency (SOL)
Time Frame: Baseline, 9 weeks
|
Data collected from sleep diary: Time fell asleep - Time attempting to fall asleep
|
Baseline, 9 weeks
|
Wake after sleep onset (WASO)
Time Frame: Baseline, 9 weeks
|
Data collected from sleep diary: Total time awake between time feel asleep and final morning waking
|
Baseline, 9 weeks
|
Perceived sleep quality
Time Frame: Baseline, 9 weeks
|
Data collected from sleep diary: Nightly rating of perceived sleep quality from very poor to very good
|
Baseline, 9 weeks
|
Sleep-related cognitions
Time Frame: Baseline, 9 weeks
|
Dysfunctional Beliefs and Attitudes about Sleep; 16 items; averaged scores range from 0 to 10 (higher scores indicate more dysfunctional attitudes and beliefs about sleep)
|
Baseline, 9 weeks
|
Sleep self-efficacy
Time Frame: Baseline, 9 weeks
|
Sleep Self-Efficacy Scale; 13-items; averaged scores range from 0 to 10 (higher scores indicate greater self-efficacy)
|
Baseline, 9 weeks
|
Internal and chance sleep locus of control
Time Frame: Baseline, 9 weeks
|
Sleep Locus of Control Scale; 4-item subscales for internal and chance locus of control, respectively; averaged scores per scale range from 1 to 6 (higher scores indicate higher belief in the locus of control measured)
|
Baseline, 9 weeks
|
Caregiving burden
Time Frame: Baseline, 9 weeks
|
Pearlin Stress Scale - Overload subscale; 4 items; averaged scores range from 1 to 4 (higher scores indicate greater perceived burden)
|
Baseline, 9 weeks
|
Caregiving competence
Time Frame: Baseline, 9 weeks
|
Pearlin Stress Scale - Caregiving Competence subscale; 4 items; averaged scores range from 1 to 4 (higher scores indicate greater perceived competence)
|
Baseline, 9 weeks
|
Physical Function
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Physical Function 8b; 8 items; scored on a normalized T-score distribution (higher scores indicate higher physical function)
|
Baseline, 9 weeks
|
Anxiety
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Anxiety 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher anxiety)
|
Baseline, 9 weeks
|
Depression
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Depression 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher depression)
|
Baseline, 9 weeks
|
Fatigue
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Fatigue 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher fatigue)
|
Baseline, 9 weeks
|
Sleep Disturbance
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Sleep Disturbance 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher sleep disturbance)
|
Baseline, 9 weeks
|
Social functioning
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Ability to Participant in Social Roles and Activities 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher social function)
|
Baseline, 9 weeks
|
Pain Interference
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Pain Interference 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher pain interference)
|
Baseline, 9 weeks
|
Pain Intensity
Time Frame: Baseline, 9 weeks
|
PROMIS SF v2.0 - Pain Intensity item; 1 item (higher score indicate higher pain intensity)
|
Baseline, 9 weeks
|
Experiences with Internet intervention
Time Frame: 9 weeks
|
Internet Intervention Utility Questionnaire (UQ) for SHUTi; 18 items; items examined individually
|
9 weeks
|
Perceptions of Internet intervention
Time Frame: 9 weeks
|
Internet Intervention Impact and Effectiveness Questionnaire (IEQ) for SHUTi; 29 items; items examined individually
|
9 weeks
|
Adherence to Internet intervention
Time Frame: 9 weeks
|
Internet Intervention Adherence Questionnaire (AQ) for SHUTi; 20 items; items examined individually
|
9 weeks
|
SHUTi Feasibility as assessed by open-ended feedback
Time Frame: 9 weeks
|
Open-ended survey items regarding barriers to using SHUTi
|
9 weeks
|
SHUTi Acceptability as assessed by open-ended feedback
Time Frame: 9 weeks
|
Open-ended survey items regarding appropriateness of SHUTi to address caregivers' sleep needs
|
9 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kelly Shaffer, PhD, University of Virginia
Publications and helpful links
General Publications
- Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C, Quigg MS, Cohn WF, Morin CM. Effect of a Web-Based Cognitive Behavior Therapy for Insomnia Intervention With 1-Year Follow-up: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Jan 1;74(1):68-75. doi: 10.1001/jamapsychiatry.2016.3249.
- Shaffer KM, Garland SN, Mao JJ, Applebaum AJ. Insomnia among Cancer Caregivers: A Proposal for Tailored Cognitive Behavioral Therapy. J Psychother Integr. 2018 Sep;28(3):275-291. doi: 10.1037/int0000105.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3809
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
Clinical Trials on SHUTi (Sleep Healthy Using the Internet)
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthma | Insomnia ChronicUnited States
-
University of VirginiaCompletedCancer | InsomniaUnited States
-
Henry M. Jackson Foundation for the Advancement...Uniformed Services University of the Health Sciences; Center for Neuroscience...CompletedMild Traumatic Brain Injury | Insomnia ChronicUnited States
-
University of VirginiaNational Institute of Mental Health (NIMH)CompletedInsomnia | Sleep Initiation and Maintenance DisordersUnited States
-
University of VirginiaUniversity of PittsburghCompletedInsomnia | Sleep Initiation and Maintenance Disorders | Family CaregiversUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)RecruitingInsomnia | Sleep | Childhood Cancer | Survivorship | Late Effect | Neurocognitive ImpairmentUnited States
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
University of VirginiaNational Institute on Aging (NIA); Laval UniversityCompletedInsomnia | Sleep Initiation and Maintenance DisordersUnited States
-
National Institutes of Health Clinical Center (CC)University of Pennsylvania; University of VirginiaCompletedAlcohol Dependence | Insomnia | Alcohol Use DisorderUnited States
-
St. Olavs HospitalRecruitingMultiple Sclerosis | InsomniaNorway